Taking place on the first day of ASCO, the 5th Annual Immuno-Oncology: BD&L and Investment Forum is designed to bring together thought leaders from cancer research institutes, patient advocacy groups, pharma and biotech to facilitate partnering, funding and investment. We expect around 250 delegates and about 30 presentations by listed and private biotechnology companies seeking licensing & investment.

Numerous networking opportunities available via an online One-to-One meeting system with dedicated meeting facilities to make the event more transactional.

15% registration discount for SBA members. Taking place on the first day of ASCO, the 5th Annual Immuno-Oncology: BD&L and Investment Forum is designed to facilitate partnering, funding and investment. We expect around 250 delegates and about 30 presentations by listed and private biotechnology companies seeking licensing & investment.

Details
Location